All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition
During the 3rd European CAR T-cell Meeting, the Lymphoma Hub spoke to Jordan Gauthier, Fred Hutchinson Cancer Research Center, Seattle, US. We asked, When is a second CAR T-cell infusion feasible following unsuccessful prior CAR T-cell therapy?
When is a second CAR T-cell infusion feasible following unsuccessful prior CAR T-cell therapy?
For patients who do not respond to the first round of CAR T-cell infusion, the best course of treatment is unknown but one option is to give a second dose. In this video, Jordan Gauthier discusses the data from 44 patients with B-cell malignancies.
How good are we in generating CAR T-cells in a virus-free environment?
During the 3rd European CAR T-cell Meeting, the Lymphoma Hub spoke to Michael Hudecek, Julius-Maximilians-Universität Würzburg, Würzburg, DE. We asked, How good are we in...
Antibiotic treatment is associated with decreased response to CAR T-cell therapy
The health and diversity of the gut microbiome has been recognized to play a role in numerous health conditions. In particular, a link has been noted between the...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox